Prevalence and characteristics of psoriasis in Denmark: findings from the Danish skin cohort
- PMID: 30898836
- PMCID: PMC6475143
- DOI: 10.1136/bmjopen-2018-028116
Prevalence and characteristics of psoriasis in Denmark: findings from the Danish skin cohort
Abstract
Background: Wide-ranging psoriasis prevalence estimates have been reported, possibly due to methodological differences.
Objectives: To assess the prevalence of psoriasis in Denmark and to validate the use of questionnaire-based data to identify patients with psoriasis.
Methods: We used data from the Danish Skin Cohort, a prospective cohort comprising general population adults, as well as patients with dermatologist-verified psoriasis and atopic dermatitis, respectively. The general population cohort was interviewed to assess the psoriasis prevalence in Denmark, and validation of the questions was performed.
Results: From 3490 general population participants, 7.9% (n=275) were found to have self-reported psoriasis. Of these, 221 (prevalence 6.3%) had their disease diagnosed by a physician (the dermatologist-diagnosed prevalence was 4.3%), whereas 54 (prevalence 1.6%) were not diagnosed by a physician. A total of 176 (5%) had active psoriasis within the last 12 months. More than half of patients had at least one disease flare in the last 12 months, and 44.4% of patients with psoriasis had at least one family member with psoriasis, whereas this was only the case for 13.7% of non-psoriasis individuals. Validation of the psoriasis diagnosis yielded a high sensitivity and specificity, with little incremental value of limiting diagnoses to those diagnosed by a physician.
Conclusion: The lifetime-prevalence of self-reported psoriasis was found to be 7.9%, whereas the 1-year prevalence (ie, currently active psoriasis) was 5.0%. If used appropriately, questionnaire-based data may accurately identify patients with psoriasis.
Keywords: epidemiology; nationwide; prevalence; psoriasis; validation.
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
-
Frequency of Atopic Dermatitis and Psoriasis in the Elderly: Cross-Sectional Findings from the German AugUR Study.Dermatology. 2025;241(1):1-9. doi: 10.1159/000541590. Epub 2024 Sep 27. Dermatology. 2025. PMID: 39342937 Free PMC article.
-
Erectile Dysfunction in Male Adults With Atopic Dermatitis and Psoriasis.J Sex Med. 2017 Mar;14(3):380-386. doi: 10.1016/j.jsxm.2016.12.233. Epub 2017 Jan 18. J Sex Med. 2017. PMID: 28109691
-
Limitations of Using Questionnaires for Assessing the Prevalence of Psoriasis and Atopic Dermatitis Among Adults.JAMA Dermatol. 2021 Aug 1;157(8):971-977. doi: 10.1001/jamadermatol.2021.2307. JAMA Dermatol. 2021. PMID: 34232252 Free PMC article.
-
Psoriasis and comorbidities. Epidemiological studies.Dan Med J. 2016 Feb;63(2):B5201. Dan Med J. 2016. PMID: 26836804 Review.
-
Psoriasis--epidemiology and clinical spectrum.Clin Exp Dermatol. 2001 Jun;26(4):314-20. doi: 10.1046/j.1365-2230.2001.00832.x. Clin Exp Dermatol. 2001. PMID: 11422182 Review.
Cited by
-
Psoriasis Among Adolescents in Kuwait and the Role of Siblings, Breastfeeding, and Household Cat and Secondhand Smoke Exposure: A Cross-Sectional Study.Dermatol Ther (Heidelb). 2020 Oct;10(5):1137-1153. doi: 10.1007/s13555-020-00437-0. Epub 2020 Aug 25. Dermatol Ther (Heidelb). 2020. PMID: 32844373 Free PMC article.
-
Adverse events from topical corticosteroid use in chronic hand eczema - Findings from the Danish Skin Cohort.JAAD Int. 2023 Dec 3;14:77-83. doi: 10.1016/j.jdin.2023.11.004. eCollection 2024 Mar. JAAD Int. 2023. PMID: 38274394 Free PMC article.
-
Risk factors that limit use of oral JAK inhibitors in chronic hand eczema: Findings from the Danish Skin Cohort.JAAD Int. 2024 Sep 2;17:61-66. doi: 10.1016/j.jdin.2024.08.006. eCollection 2024 Dec. JAAD Int. 2024. PMID: 39411234 Free PMC article.
-
Regular support provided by dermatological nurses improves outcomes in patients with psoriasis treated with topical drugs: a randomized controlled trial.Clin Exp Dermatol. 2022 Dec;47(12):2208-2221. doi: 10.1111/ced.15370. Epub 2022 Oct 25. Clin Exp Dermatol. 2022. PMID: 35973788 Free PMC article. Clinical Trial.
-
Clinical Trials in Nail Psoriasis: Cross-Sectional Analysis of the Current State of Research.Skin Appendage Disord. 2025 Jun;11(3):232-244. doi: 10.1159/000542568. Epub 2024 Nov 12. Skin Appendage Disord. 2025. PMID: 40475100
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical